One Drop Appoints Luc Gregoire as Chief Financial Officer

One Drop Appoints Luc Gregoire as Chief Financial Officer

Seasoned Chief Financial Officer to accelerate One Drop’s expansion amid growth of digital healthcare market

NEW YORK, February 9, 2021 — One Drop, a leader in digital solutions for people living with diabetes and other chronic conditions, today announced the appointment of Luc Gregoire as the Chief Financial Officer (CFO) and the newest member of the corporate leadership team. Effective immediately, Mr. Gregoire will assume responsibility for One Drop’s accounting and financial operations and serve as a strategic business advisor to the Chief Executive Officer (CEO) and founder, Jeff Dachis.

“We are excited that Luc is joining One Drop at such a pivotal stage of our growth,” said Jeff Dachis, One Drop CEO. “Luc’s demonstrated financial and strategic leadership scaling healthcare and data-oriented technology companies, coupled with his extensive experience in capital markets, both private and public, will be instrumental in shepherding and accelerating One Drop’s growth.”

Mr. Gregoire brings over 30 years of financial, strategic, and operational experience in public and private capital markets across various industries including software, digital media, entertainment, and health sciences. Most recently, he served as CFO of DHI Group, Inc. (NYSE:DHX), a leading online provider of technology career marketplaces. While there, he helped realign the company’s strategy and structure, significantly improving its financial position by stabilizing revenues and improving profitability while also reinvigorating the company’s capital markets strategy.

Prior to DHI Group, Inc., Mr. Gregoire was CFO of Avepoint, Inc., a venture-backed enterprise SaaS company. For over 13 years, he was at Merck & Co, Inc. (NYSE: MRK), where he served in several senior finance, business development, strategy, and operational roles across geographies and therapeutic franchises. Mr. Gregoire has also held several U.S. and global senior leadership positions across different sectors, including Take Two Interactive, Inc. (NASDAQ: TTWO), maker of Grand Theft Auto and NBA 2K, among others, and The McGraw-Hill Companies, Inc. (NYSE: MHFI). He was also previously a partner at Arthur Andersen. Mr. Gregoire is a Canadian Certified Public Accountant (CPA) with a graduate degree in public accountancy from McGill University.

“I am inspired and thrilled to be joining the One Drop team at such a critical juncture of opportunity for the Company,” said Mr. Gregoire. “I look forward to leveraging my experience in leading companies through different stages of growth along with my knowledge of healthcare and technology to help us execute and fulfill One Drop’s noble mission of transforming how people can manage their health.”

The seasoned financial, strategic, and operational executive joins on the heels of a momentous year of growth and innovation for One Drop. In 2020, One Drop launched its first digital-only offering for consumers, acquired all the assets and intellectual property of Sano Intelligence, Inc., and secured nearly $100 million in financing and commitments from global partner, Bayer AG. One Drop plans to expand into even more therapeutics areas, such as cardiology and women’s health, in combination with the development of a continuous multi-analyte dermal sensor, accelerating the company’s data science efforts.

To date, One Drop has amassed over 19 billion longitudinal health data points from 4.6 million users who have downloaded the One Drop app in over 195 countries. This immense data wealth powers One Drop's proprietary machine learning models, generating physiological predictions such as blood sugar levels and blood pressure, paired with relevant behavioral recommendations. The result is a continuous real-time feedback loop that drives behavior change, which as part of a healthy lifestyle, can lead to improved health outcomes for people with diabetes and other chronic conditions. One Drop's digital health platform has been available to consumers, employers, insurers, and healthcare providers since 2016.

This press release contains forward-looking statements. Such forward-looking statements reflect the views of management at the time such statements are made. These forward-looking statements involve risks and uncertainties, as well as assumptions and current expectations, which could cause the company's actual results to differ materially from those anticipated in such forward-looking statements. These risks and uncertainties include but are not limited to: change in demand for the company's products due to industry conditions; the company's reliance on a small number of customers for a substantial portion of its revenues; potential pricing pressure; a decline in demand for our customers' products or their rate of deployment of their products; general conditions in the markets in which we operate; changes in the world economy; and other risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as "believe," "estimate," "anticipate," "intend," "target," "seek," "believe," "expect," or "plan" or by other similar expressions that convey uncertainty of future events or outcomes. You should not rely on forward-looking statements as predictions of future events. All forward-looking statements in this press release are based upon information available to us as of the date hereof, and qualified in their entirety by this cautionary statement. Except as required by law, we assume no obligation to update forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in the company's expectations.